Molly A. Holman

Corporate Officer/Principal at Metabasis Therapeutics, Inc.

Consumer Services

Health Technology

Profile

Molly A.
Holman is currently the Vice President-Intellectual Property at Metabasis Therapeutics, Inc. She was previously the Executive Director-Intellectual Property at Amylin Pharmaceuticals, Inc. from 2001 to 2007.
Holman has a graduate degree from the University of California, Los Angeles, a doctorate from the University of California, Irvine, and an undergraduate degree from the University of California, Riverside.

Molly A. Holman active positions

Companies	Position	Start
Metabasis Therapeutics, Inc. Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.	Corporate Officer/Principal	2008-09-08

All active positions of Molly A. Holman

Former positions of Molly A. Holman

Companies	Position	End
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.	Corporate Officer/Principal	2006-12-31

See the detail of Molly A. Holman's experience

Training of Molly A. Holman

University of California, Riverside	Undergraduate Degree
University of California, Irvine	Doctorate Degree
University of California, Los Angeles	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Molly A. Holman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Metabasis Therapeutics, Inc. Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.	Health Technology
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.	Health Technology